바이러스 클리어런스 서비스 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
Viral Clearance Service Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1818379
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,558,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,713,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,724,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,178,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계 바이러스 클리어런스 서비스 시장의 미래는 유망하며, 연구기관과 제약산업 시장에서 기회가 있을 것으로 보입니다. 세계 바이러스 클리어런스 서비스 시장은 2025년부터 2031년까지 CAGR 17.2%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 생물학적 제제 및 바이오시밀러 생산량 증가와 바이오 제약사의 아웃소싱 확대입니다.

바이러스 클리어런스 서비스 시장의 새로운 동향

세계 바이러스 클리어런스 서비스 시장은 몇 가지 새로운 트렌드에 의해 재편되고 있습니다. 이러한 추세는 기술 발전, 규제 요건의 변화, 바이오의약품 산업의 확장에 큰 영향을 받고 있습니다. 기업들은 바이러스 클리어런스 효율을 높이고 비용을 절감하며 안전한 생물학적 제제에 대한 수요 증가에 대응하기 위해 점점 더 새로운 방법을 채택하고 있습니다. 또한, 맞춤형 의료와 유전자 치료의 성장이 이 시장의 발전에 기여하고 있습니다.

세계 바이러스 클리어런스 서비스 시장의 새로운 트렌드는 기술 발전, 유전자 치료 및 맞춤형 의료에 대한 수요 증가, 신흥 시장에서의 바이오의약품 제조의 부상, 규제 요건 강화로 인해 형성되고 있습니다. 이러한 추세는 바이러스 클리어런스 기술의 혁신을 촉진하고 시장의 미래 방향성을 형성하고 있습니다. 바이오 제약 산업이 전 세계적으로 계속 확대됨에 따라 효율적이고 비용 효율적이며 정확한 바이러스 클리어런스 솔루션에 대한 수요가 증가하고 있으며, 이 시장에 진입하는 기업에게는 큰 기회가 될 것입니다.

바이러스 클리어런스 서비스 시장의 최근 동향

세계 바이러스 클리어런스 서비스 시장의 최근 동향은 안전하고 우수한 품질의 바이오의약품에 대한 수요 증가와 규제 요건의 강화를 반영하고 있습니다. 유전자 치료의 부상, 생물학적 제제의 생산 확대, 바이러스 감염의 증가 등으로 바이러스 클리어런스 서비스의 필요성이 높아지고 있습니다. 바이러스 검출 및 통관 방법의 기술적 진보와 생물학적 제제의 바이러스 안전성 유지에 대한 규제 압력이 높아지면서 시장 진화를 촉진하는 주요 요인으로 작용하고 있습니다.

세계 바이러스 클리어런스 서비스 시장의 최근 동향은 바이오의약품에서 바이러스 안전성 확보의 중요성이 높아지고 있음을 반영하고 있습니다. 기술 발전, 연구 투자 증가, 규제 기준 강화가 시장 성장을 견인하고 있습니다. 또한, 맞춤형 의료의 부상과 신흥 시장에서의 바이오의약품 분야의 확대도 바이러스 클리어런스 서비스에 대한 수요 확대에 기여하고 있으며, 이는 서비스 제공업체에게 큰 기회로 작용하고 있습니다. 이러한 흐름은 업계의 미래를 형성하고, 생물학적 제제의 안전성을 보장하며, 전 세계적으로 환자들의 건강을 증진시키고 있습니다.

목차

제1장 주요 요약

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 바이러스 클리어런스 서비스 시장 : 종류별

제5장 세계의 바이러스 클리어런스 서비스 시장 : 용도별

제6장 지역 분석

제7장 북미의 바이러스 클리어런스 서비스 시장

제8장 유럽의 바이러스 클리어런스 서비스 시장

제9장 아시아태평양의 바이러스 클리어런스 서비스 시장

제10장 기타 지역(ROW) 바이러스 클리어런스 서비스 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 위 주요 기업 개요

제14장 부록

KSM
영문 목차

영문목차

The future of the global viral clearance service market looks promising with opportunities in the research institution and pharmaceutical markets. The global viral clearance service market is expected to grow with a CAGR of 17.2% from 2025 to 2031. The major drivers for this market are the rising biologics and biosimilars production and the growing outsourcing by biopharma companies.

Emerging Trends in the Viral Clearance Service Market

The global viral clearance service market is being reshaped by several emerging trends. These trends are largely influenced by technological advancements, changing regulatory requirements, and the expanding biopharmaceutical industry. Companies are increasingly adopting new methods to improve viral clearance efficiency, reduce costs, and meet the rising demand for safe biologics. Furthermore, the growth of personalized medicine and gene therapies is contributing to the evolution of this market.

The emerging trends in the global viral clearance service market are being shaped by technological advancements, increased demand for gene therapies and personalized medicine, the rise of biopharmaceutical manufacturing in emerging markets, and stricter regulatory requirements. These trends are driving innovation in viral clearance technologies and shaping the future direction of the market. As the biopharmaceutical industry continues to expand globally, the need for efficient, cost-effective, and precise viral clearance solutions will only increase, creating significant opportunities for companies in this market.

Recent Developments in the Viral Clearance Service Market

Recent developments in the global viral clearance service market reflect the growing demand for safe, high-quality biopharmaceutical products and stricter regulatory requirements. The rise of gene therapies, the expansion of biologics production, and the increasing number of viral outbreaks have all contributed to the increased need for viral clearance services. Technological advancements in viral detection and clearance methods, along with the growing regulatory pressure to maintain viral safety in biologic products, are key drivers of the market's evolution.

Recent developments in the global viral clearance service market reflect the growing importance of ensuring viral safety in biopharmaceutical products. Advancements in technology, increased investment in research, and stricter regulatory standards are driving the market's growth. The rise of personalized medicine and the expanding biopharmaceutical sector in emerging markets are also contributing to the increased demand for viral clearance services, creating significant opportunities for service providers. These trends are shaping the future of the industry, ensuring the safety of biologics and enhancing patient health globally.

Strategic Growth Opportunities in the Viral Clearance Service Market

The global viral clearance service market is experiencing significant growth due to advancements in the biopharmaceutical and biotechnology sectors, increasing regulatory pressure, and a rising demand for viral safety in biologics, vaccines, and gene therapies. Companies are increasingly focusing on implementing more effective and cost-efficient viral clearance technologies to ensure patient safety and meet stringent regulatory standards. As a result, various applications in viral clearance, including biologics, cell and gene therapies, vaccines, and others, are creating unique opportunities for growth. These developments are positioning viral clearance services as an essential component in the production of safe and effective biopharmaceutical products.

The global viral clearance service market is poised for significant growth across various key applications, including biologics production, cell and gene therapies, vaccines, recombinant proteins, and biomanufacturing. Each application offers unique opportunities for viral clearance service providers to innovate and expand their offerings to meet the rising demand for safer, more efficient biopharmaceutical products. As these sectors continue to grow, the need for specialized viral clearance solutions will become more critical, positioning the market for sustained growth in the coming years.

Viral Clearance Service Market Driver and Challenges

The global viral clearance service market is influenced by several technological, economic, and regulatory drivers. At the same time, challenges such as the complexity of viral clearance methods, high operational costs, and regulatory hurdles remain significant. As biopharmaceuticals and biotechnology industries evolve, these factors are shaping the development of the viral clearance service market. The increasing prevalence of viral outbreaks, rising consumer demand for biologic therapies, and growing regulatory requirements are key drivers, while cost challenges, technical barriers, and regulatory uncertainties continue to create obstacles for market players.

The factors responsible for driving the viral clearance service market include:

1. Technological Advancements in Viral Clearance Methods: Technological advancements are one of the primary drivers of growth in the global viral clearance service market. As the complexity of biopharmaceuticals increases, companies are investing in advanced viral clearance methods such as chromatography, filtration, and virus inactivation to meet regulatory standards and ensure product safety. Innovations such as improved filtration systems and the development of real-time viral detection technologies are making the process more efficient and cost-effective. These advancements not only enhance the safety of biologics, vaccines, and gene therapies but also open up new opportunities for service providers in the market.

2. Increasing Demand for Biologics and Biopharmaceuticals: The rapid growth in the biologics and biopharmaceuticals sector is a key driver for the demand for viral clearance services. Biologics, including monoclonal antibodies, vaccines, and gene therapies, are increasingly being used to treat chronic diseases, cancers, and genetic disorders. As these products become more prevalent, the need for viral clearance becomes critical to ensure patient safety. The increasing number of biologic drug approvals and the expansion of the biopharmaceutical industry will continue to drive the demand for viral clearance services.

3. Regulatory Pressures and Compliance Requirements: Stringent regulatory frameworks across regions like the United States, Europe, and Asia have increased the need for comprehensive viral clearance services. Regulatory agencies such as the FDA, EMA, and CFDA are enforcing stricter safety guidelines for the production of biologics and vaccines. The need to comply with these regulations is pushing biopharmaceutical companies to invest in advanced viral clearance technologies. This is driving demand for service providers who can ensure compliance with the regulatory requirements for viral safety in biologic and vaccine production.

4. Global Health Concerns and Viral Outbreaks: The rise in viral outbreaks, such as the COVID-19 pandemic, has heightened global awareness of the importance of viral clearance in biopharmaceutical production. As a result, there is a growing demand for technologies and services that can effectively eliminate viral contamination from biopharmaceutical products. The global health crisis has brought to the forefront the need for efficient viral clearance solutions, particularly for vaccines, biologics, and therapeutics aimed at preventing and treating infectious diseases. This trend is likely to continue as new viral outbreaks emerge.

5. Adoption of Gene and Cell-Based Therapies: The rapid development and adoption of gene and cell-based therapies are creating new opportunities for viral clearance services. These therapies, which often rely on viral vectors to deliver genetic material to target cells, require specialized viral clearance solutions. The expansion of gene therapy applications in areas such as oncology, genetic disorders, and immunotherapies is increasing the demand for viral clearance services. Providers that can offer tailored solutions for gene and cell therapies will benefit from significant market opportunities.

Challenges in the viral clearance service market are:

1. Complexity of Viral Clearance Processes Viral clearance methods can be complex, especially in the production of gene therapies and biologics. The variability in viral contaminants and the different nature of viral vectors pose challenges for developing universal solutions. This complexity increases the time, cost, and effort required to develop effective viral clearance strategies, presenting challenges for both service providers and biopharmaceutical companies.

2. High Operational and R&D Costs Viral clearance testing is expensive, requiring specialized equipment, skilled personnel, and extensive testing protocols. The cost of implementing these services can be prohibitive, especially for smaller biopharmaceutical companies. This high operational cost can limit the accessibility of viral clearance services and slow the adoption of new technologies in some regions.

3. Regulatory Uncertainties Despite clear guidelines in certain regions, the regulatory landscape for viral clearance services is still evolving. Different agencies across the globe may have varying requirements, and changes in regulations can create uncertainty for biopharmaceutical companies. This can delay the approval and adoption of new viral clearance technologies and make compliance more challenging.

The drivers of technological advancements, increasing demand for biologics, stringent regulatory pressures, and the rise of gene and cell therapies are propelling the growth of the global viral clearance service market. However, challenges such as the complexity of viral clearance processes, high operational costs, and regulatory uncertainties pose significant obstacles for the market. The ability of service providers to navigate these challenges while capitalizing on emerging opportunities will determine their success in this rapidly evolving market.

List of Viral Clearance Service Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies viral clearance service companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the viral clearance service companies profiled in this report include-

Viral Clearance Service Market by Segment

The study includes a forecast for the global viral clearance service market by type, application, and region.

Viral Clearance Service Market by Type [Value from 2019 to 2031]:

Viral Clearance Service Market by Application [Value from 2019 to 2031]:

Viral Clearance Service Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the Viral Clearance Service Market

The global viral clearance service market has seen notable growth in recent years, driven by increasing regulatory demands, advancements in viral clearance technologies, and rising concerns over viral contamination in biopharmaceutical manufacturing. With the continued expansion of the global pharmaceutical market, the need for effective and efficient viral clearance services has become a critical focus for companies looking to ensure the safety of their biopharmaceutical products. These services are particularly important in biologics, cell and gene therapies, and vaccines, where viral contamination could have serious public health consequences. Various regions, including the United States, China, Germany, India, and Japan, have witnessed significant advancements in viral clearance services, driven by regulatory pressures and growing market demand.

Features of the Global Viral Clearance Service Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global Viral Clearance Service Market by Type

5. Global Viral Clearance Service Market by Application

6. Regional Analysis

7. North American Viral Clearance Service Market

8. European Viral Clearance Service Market

9. APAC Viral Clearance Service Market

10. ROW Viral Clearance Service Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기